Cargando…
Modern sulphonylureas and cardiovascular adverse effects: Will CAROLINA put an end to the controversy?
Sulphonylureas (SU) form an important role in management of people with type 2 diabetes. This safety history of SU was tainted for various reasons, the predominant one being lack of demonstration of cardiovascular safety. Since its introduction, SU's have never been subjected to a formal study...
Autores principales: | John, Mathew, Kalra, Sanjay, Nair, Tiny |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7474120/ https://www.ncbi.nlm.nih.gov/pubmed/32861392 http://dx.doi.org/10.1016/j.ihj.2020.07.009 |
Ejemplares similares
-
The identification of the Romanovs: Can we (finally) put the controversies to rest?
por: Coble, Michael D
Publicado: (2011) -
Probiotics for preterm infants – time to end all controversies
por: Athalye‐Jape, Gayatri, et al.
Publicado: (2019) -
Putting an end to the Pseudomonas aeruginosa IQS controversy
por: Cornelis, Pierre
Publicado: (2019) -
EPISOD puts an end to sphincter of Oddi dysfunction type III
por: Mosko, Jeffrey D., et al.
Publicado: (2014) -
Cardiovascular outcome trials for anti-diabetes medication: A holy grail of drug development?
por: John, Mathew, et al.
Publicado: (2016)